155 related articles for article (PubMed ID: 8667626)
1. Improvement of pharmacokinetics and antitumor activity against human hepatoma cell line by using adriamycin-entrapped stealth liposomes.
Shimizu H; Kumai K; Uyama I; Shibata S; Tagawa T; Nagaike K; Yasuda T; Kitajima M; Tadakuma T
J Surg Oncol; 1996 Jul; 62(3):186-93. PubMed ID: 8667626
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody.
Konno H; Suzuki H; Tadakuma T; Kumai K; Yasuda T; Kubota T; Ohta S; Nagaike K; Hosokawa S; Ishibiki K
Cancer Res; 1987 Aug; 47(16):4471-7. PubMed ID: 2440568
[TBL] [Abstract][Full Text] [Related]
3. [Experimental studies on targeting chemotherapy using adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody].
Suzuki H
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):257-65. PubMed ID: 1711147
[TBL] [Abstract][Full Text] [Related]
4. [Importance of the conjugated antibody for the induction of selective effect of adriamycin conjugated with anti AFP monoclonal antibody and entrapped in liposomes against AFP producing tumors].
Konno H; Kumai K; Tsubouchi T; Ishibiki K; Abe O; Tadakuma T; Yasuda T; Nagaike K; Hosokawa S; Sakaguchi S
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2213-7. PubMed ID: 2472119
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of metastatic carcinoma cell growth in livers by poly(I):poly(C)/cationic liposome complex (LIC).
Hirabayashi K; Yano J; Takesue H; Fujiwara N; Irimura T
Oncol Res; 1999; 11(11-12):497-504. PubMed ID: 10905561
[TBL] [Abstract][Full Text] [Related]
6. The effect of adriamycin against a liver metastatic model by encapsulation in liposomes.
Yachi K; Suzuki N; Tanaka N; Okada K; Mitsui I; Kawato Y; Komagata Y; Komiyama K; Kikuchi H
Biopharm Drug Dispos; 1996 Nov; 17(8):699-715. PubMed ID: 8950048
[TBL] [Abstract][Full Text] [Related]
7. Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio.
Lopez-Barcons LA; Polo D; Llorens A; Reig F; Fabra A
Oncol Rep; 2005 Nov; 14(5):1337-43. PubMed ID: 16211306
[TBL] [Abstract][Full Text] [Related]
8. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
Cheng WW; Allen TM
J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein or anti-carcinoembryonic antigen monoclonal antibodies].
Konno H
Nihon Geka Gakkai Zasshi; 1986 Apr; 87(4):365-74. PubMed ID: 2423862
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of adriamycin entrapped in liposomes conjugated with monoclonal antibody against tumor-associated antigen of bovine leukemia cells.
Onuma M; Odawara T; Watarai S; Aida Y; Ochiai K; Syuto B; Matsumoto K; Yasuda T; Fujimoto Y; Izawa H
Jpn J Cancer Res; 1986 Nov; 77(11):1161-7. PubMed ID: 3025145
[TBL] [Abstract][Full Text] [Related]
12. [Fundamental studies of targeting cancer chemotherapy against choriocarcinoma--application of liposome].
Tadera S; Yamanaka N; Kamidono S
Hinyokika Kiyo; 1989 Feb; 35(2):209-15. PubMed ID: 2735231
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
Lopes de Menezes DE; Pilarski LM; Allen TM
Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.
Gabizon A; Goren D; Fuks Z; Barenholz Y; Dagan A; Meshorer A
Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331
[TBL] [Abstract][Full Text] [Related]
15. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles.
Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ
Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183
[TBL] [Abstract][Full Text] [Related]
16. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposomes and adriamycin].
Li WJ; Qian HN; Lu WY
Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):539-41, 582. PubMed ID: 7842351
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
Allen TM; Mumbengegwi DR; Charrois GJ
Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
[TBL] [Abstract][Full Text] [Related]
18. A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor.
He X; Na MH; Kim JS; Lee GY; Park JY; Hoffman AS; Nam JO; Han SE; Sim GY; Oh YK; Kim IS; Lee BH
Mol Pharm; 2011 Apr; 8(2):430-8. PubMed ID: 21222482
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts.
Sakakibara T; Chen FA; Kida H; Kunieda K; Cuenca RE; Martin FJ; Bankert RB
Cancer Res; 1996 Aug; 56(16):3743-6. PubMed ID: 8706018
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study on targeting therapy of human hepatocellular carcinoma in nude mice using adriamycin-anti-transferrin receptor conjugate].
Wang F; Li S; Lin J
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):354-7. PubMed ID: 8697974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
